Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX)

178 filings reported holding ABVX - Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share as of Q3 2025.
Abivax S.A. - Ordinary Shares, par value Euro 0.01 per share (ABVX) has 165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 51,964,814 shares of 78,149,407 outstanding shares and own 66% of the company stock.
Largest 10 shareholders include TCG Crossover Management, LLC (7,111,596 shares), UBS Group AG (4,461,262 shares), Darwin Global Management, Ltd. (3,164,501 shares), Point72 Asset Management, L.P. (2,925,352 shares), Cormorant Asset Management, LP (1,950,000 shares), Paradigm Biocapital Advisors LP (1,564,196 shares), MORGAN STANLEY (1,470,717 shares), Caligan Partners LP (1,451,924 shares), FMR LLC (1,430,673 shares), and ADAR1 Capital Management, LLC (1,350,826 shares).
This table shows the top 165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.